secwatch.observer — SEC 8-K summary
======================================

Issuer:     Invivyd, Inc. (IVVD)
CIK:        0001832038
Form:       8-K
Filed at:   2022-12-06T23:59:59+00:00
Accession:  0001193125-22-299428
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Invivyd appoints Jeremy Gowler as COO/CCO, promotes Pete Schmidt to CMO
-----------------------------------------------------------------------

- Jeremy Gowler appointed COO and CCO effective Dec 16, 2022; 20 years pharma commercial experience from Sandoz/Novartis.
- Pete Schmidt promoted to CMO effective immediately; previously VP clinical research; CDO Hershberger departing but consulting.
- Gowler receives $440K base salary, $150K signing bonus, target annual bonus 40%, and option grant of 625,000 shares.
- Option vests 25% after 1 year then monthly over 3 years; severance includes 9-12 months salary depending on circumstances.
- Company advancing pipeline of monoclonal antibodies against COVID-19 and other respiratory viruses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832038/000119312522299428/0001193125-22-299428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832038/000119312522299428/d422123d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-299428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer